Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Plenary Session 3203

Environment and Neurodegeneration

Sunday, September 29, 2024
8:00 - 10:00 | Ballroom AB
Clinical, Translational

In this session, faculty will present an overview of how environmental toxins and neuroinfections may play a crucial role in neurodegeneration and the impact of climate change in the lives of patients with neurodegenerative disorders.


Chairs:
Njideka Okubadejo, Nigeria
Pramod Pal, India

Presenters:

Toxins and Other Pollutants as Risk Factors for Parkinsonism
Mohamed Salama, Egypt

Do Infections Predispose to Neurodegeneration?
Richard Smeyne, USA

Impact of Climate Change on Neurodegenerative Disorders
Mohammad Ikram, Netherlands

CSPC Liaisons:
Jonathan Carr, South Africa

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Define the role of the environment and possible environment-gene interactions in the causality of parkinsonism
  2. Describe current evidence linking neuro-infections with neurodegeneration
  3. Describe how environment and climate change impact neurodegenerative disorders

Recommended Audience
Clinician
Fellow / Resident / Student
Health Professional (non-physician)
Researcher / Basic Science

Education Level
Beginner / Foundational
Experienced / Intermediate
Expert / Advanced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice